The tweet was deleted by the author.
But we saved everything 🙂.
Pacific Biosciences of California has announced new findings supported by PacBio HiFi sequencing, highlighting advancements in rare disease research. Of particular note is a 12.1 percent diagnostic yield in previously unsolved cases, showcasing the impact of the companys sequencing technologies.
Additionally, researchers have developed a single cell atlas that spans 26 human tissues, further demonstrating the reach of HiFi and Kinnex sequencing in biomedical investigation.
View post on X Loading...
Pacific Biosciences of California has recently made its HiFi sequencing platform more accessible to biopharma researchers with the launch of Vega SPRQ-Nx. The company also provided sequencing technology for a global undiagnosed disease hackathon in Singapore, supporting collaborative efforts to address rare and unresolved conditions through innovation, as detailed here. These developments reflect the company's ongoing expansion in life sciences research applications.